Soft-Tissue Sarcoma

  • Brian Lee
  • Stuart Y. Tsuji
  • Alexander R. Gottschalk


∼10,400 cases/year and ∼3,700 deaths/year in the US Median age 40–60 years. Slight male predominance, more frequent among African-Americans. Genetics: NF-1, Retinoblastoma, Gardner’s syndrome, Li-Fraumeni syndrome. Environmental exposures: ionizing radiation, herbicides, thorotrast, chlorophenols, vinyl chloride, arsenic. Lower extremity (45%) > trunk (30%) > upper extremity (15%) > H&N (8%). Extremity = liposarcoma, MFH, synovial, fibrosarcoma, myxoid liposarcoma (upper medial thigh). Retroperitoneal = liposarcoma (fewer DM) > leiomyosarcoma (increased DM). H&N = MFH, usually high-grade (except myxoid MFH = intermediate grade). Frequency: MFH (20–30%), liposarcoma (10–20%), leiomyosarcoma (10–15%), fibrosarcoma (5–10%), synovial cell sarcoma (5–10%), rhabdomyosarcoma (5–10%), malignant peripheral nerve sheath tumor/malignant schwannoma (5%). Synovial sarcoma = usually high-grade, near (but not within) joints in tendon sheaths, bursae, and joint capsules. Grade based on cellularity, differentiation, pleomorphism, necrosis, #mitoses. Cytogenetics: See Appendix D.


Synovial Sarcoma Malignant Peripheral Nerve Sheath Tumor Tendon Sheath Myxoid Liposarcoma Medial Thigh 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



  1. Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000;47:157-163.PubMedCrossRefGoogle Scholar
  2. Davis AM, O’Sullivan B, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005; 75:48-53.PubMedCrossRefGoogle Scholar
  3. Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal Soft Tissue Sarcoma. Cancer 2005;104:669-675.PubMedCrossRefGoogle Scholar
  4. Oertel S, Treiber M, Zahlten-Hinguranage A, et al. Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2006;64:1416-1423.PubMedCrossRefGoogle Scholar
  5. O’Sullivan B, Chung P, Euler C, et al. In Gunderson LL, Tepper JE, editors. Clinical Radiation Oncology. 2nd ed. Philadelphia: Elsevier; 2007. pp. 1519-1549. 2007.Google Scholar
  6. O’Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235-2241.PubMedCrossRefGoogle Scholar
  7. Pervaiz N, Colterjohn N, Farrokhyar F, et al. A Systematic Meta-Analysis of Randomized Controlled Trials of Adjuvant Chemotherapy for Localized Resectable Soft-Tissue Sarcoma. Cancer 2008;113:573-581.PubMedCrossRefGoogle Scholar
  8. Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-868.PubMedGoogle Scholar
  9. Pollack A, Zagars GK, Goswitz MS, et al. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys 1998;42:563-572.CrossRefGoogle Scholar
  10. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305-31.PubMedCrossRefGoogle Scholar
  11. Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993;128:402-410.Google Scholar
  12. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197-203.PubMedGoogle Scholar

Further Reading

  1. Alektiar KM, Brennan MF, Healey JH, et al. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol 2008;26:3440-3444.PubMedCrossRefGoogle Scholar
  2. Ballo MT ZG. The Soft Tissue. In: Cox JD, Ang KK, editors. Radiation Oncology: Rationale, technique, results. 8th ed. St. Louis: Mosby; 2003. pp.884-911.Google Scholar
  3. Jemal A, Siegel R, Ward E, et al. Cancer Statistics 2008. CA Cancer J Clin 2008; 58:71-96.PubMedCrossRefGoogle Scholar
  4. Le Q PT, Leibel SA. Sarcomas of Soft Tissue. In Leibel SA, Phillips TL, editors. Textbook of Radiation Oncology. 2nd ed. Philadelphia: Saunders; 2004. pp. 1335-1362. 2004.Google Scholar
  5. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma. Available at: Accessed on March 23, 2009.
  6. Ray ME, McGinn CJ. In Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. pp.1808-1821. 2008.Google Scholar
  7. Tierney JF, Mosseri V, Stewart LA, et al. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 1995;72:469-475.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Brian Lee
    • 1
  • Stuart Y. Tsuji
    • 2
  • Alexander R. Gottschalk
    • 2
  1. 1.Radiation OncologySwedish HospitalSeattleUSA
  2. 2.Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations